ClinicalTrials.Veeva

Menu

Thebaine Urine Testing

Cincinnati Children's Hospital Medical Center logo

Cincinnati Children's Hospital Medical Center

Status

Enrolling

Conditions

Urine Specimen Collection

Study type

Observational

Funder types

Other

Identifiers

NCT07192887
2024-0818

Details and patient eligibility

About

To develop and validate a urine drug screen to detect thebaine.

Enrollment

20 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female
  • Ages 18-65
  • Healthy

Exclusion criteria

  • Allergy to poppy seeds, or any of the related food stuffs used in the study
  • Celiac disease or gluten sensitivity
  • Ongoing or opioid use in the past 6 months
  • History of renal or hepatic disease or dysfunction
  • Inability or unwillingness to give repeated urine specimens
  • Unwillingness to refrain from eating poppy seed-containing products during the two-day course of the study
  • Non-English speakers (due to study materials being in English)
  • BMI greater than 30
  • Antibiotic use in the previous 2 months
  • Recent ingestion of poppy seeds from the previous 7 days

Trial contacts and locations

1

Loading...

Central trial contact

Charlotte Walter, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems